Related Experiment Videos
High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer
Oncology
|January 1, 1985
Abstract:
Twenty-two patients with metastatic breast cancer refractory to conventional chemotherapeutic agents were treated with 1-beta-D-arabinofuranosylcytosine (Ara-C) at a dose of 2 g/m2 over 2 h every 12 h for 3 doses at 21-day intervals. Two patients achieved partial remission, 3 patients had less than partial response.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Erratum.
Oncology·2026
From Phase Ib/II to Seamless Phase II/III: A Simulation-Based Discussion of Design Strategies for Dose Optimization and Confirmatory Phase.
Clinical pharmacology and therapeutics·2026
Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies.
Journal of comparative effectiveness research·2026
Epidemiology of medication-related problems and antimicrobial utilisation among critically ill cancer patients: Determinants, pharmacist interventions and clinical outcomes-A prospective observational study.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Enhancing Cancer Immunotherapy with Berberine and Its Loaded Nanoparticles: A Systematic Review.
Anti-cancer agents in medicinal chemistry·2026